• About us
• Contact

Advertisement

Person › Details

Stéphane Depil (Servier (Group))

Depil, Stéphane (Servier 201112 Head Oncology Research & Development)

 

	Organisation	Servier (Group)
	Product	cancer drug
	Product 2	oncology

Record changed: 2023-01-11

Advertisement

More documents for Stéphane Depil

• [1] ErVaccine Technologies S.A.. (1/5/23). "Press Release: ErVaccine Closes a €4.5 Million Financing Round and Prepares to Start Clinical Trial with Its First Therapeutic Cancer Vaccine in 2023". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.